Selected miRNAs in oropharyngeal squamous cell carcinoma (OPSCC) with HPV and EBV coinfection

1Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, et al. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med. 2015;44(1):28-36.Search in Google Scholar

2Syrjänen S. Oral manifestations of human papillomavirus infections. Eur J Oral Sci. 2018;126(S1):49-66.Search in Google Scholar

3Carpén T, Syrjänen S, Jouhi L, Randen-Brady R, Haglund C, Mäkitie A, et al. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. Cancer Immunol Immunother. 2020;69(8):1615-26.Search in Google Scholar

4Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60-72.Search in Google Scholar

5Alibek K, Kakpenova A, Baiken Y. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer. 2013;8(1):7.Search in Google Scholar

6Hillbertz NS, Hirsch JM, Jalouli J, Jalouli MM, Sand L. Viral and molecular aspects of oral cancer. Anticancer Res. 2012;32(10):4201-12.Search in Google Scholar

7Al Moustafa AE, Chen D, Ghabreau L, Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses. 2009;73(2):184-6.Search in Google Scholar

8Makielski KR, Lee D, Lorenz LD, Nawandar DM, Chiu YF, Kenney SC, et al. Human papillomavirus promotes Epstein-Barr virus maintenance and lytic reactivation in immortalized oral keratinocytes. Virology. 2016;495:52-62.Search in Google Scholar

9Drop B, Strycharz-Dudziak M, Kliszczewska E, Polz-Dacewicz M. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in laryngeal, oropharyngeal and oral cavity cancer. Int J Mol Sci. 2017;18(12):E2752.Search in Google Scholar

10Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 are promising prognosis predictors for oral squamous cell carcinoma. Theranostics. 2019;9(4):920-31.Search in Google Scholar

11Diez-Fraile A, De Ceulaer J, Derpoorter C, Spaas C, De Backer T, Lamoral P, et al. Tracking the molecular fingerprint of head and neck cancer for recurrence detection in liquid biopsies. Int J Mol Sci. 2022;23(5):2403.Search in Google Scholar

12Dumache R. Early diagnosis of oral squamous cell carcinoma by salivary microRNAs. Clin Lab. 2017;63(11):1771-6.Search in Google Scholar

13Schneider A, Victoria B, Lopez YN, Suchorska W, Barczak W, Sobecka A, et al. Tissue and serum microRNA profile of oral squamous cell carcinoma patients. Sci Rep. 2018;8(1):675.Search in Google Scholar

14Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, et al. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer. 2016;15(1):28.Search in Google Scholar

15Romano G, Veneziano D, Acunzo M, Croce CM. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485-91.Search in Google Scholar

16Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology. 2008;382(2):257-66.Search in Google Scholar

17Wang Z, Qiao Q, Chen M, Li X, Wang Z, Liu C, et al. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Letters. 2014;588(6):915-21.Search in Google Scholar

18Zhang M, Xiong F, Zhang S, Guo W, He Y. Crucial roles of miR-625 in human cancer. Front Med (Lausanne). 2022;9:845094.Search in Google Scholar

19Lu Z, He Q, Liang J, Li W, Su Q, Chen Z, et al. miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids. 2019;16:471-80.Search in Google Scholar

20Yi SJ, Liu P, Chen BL, Ou-Yang L, Xiong WM, Su JP. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma. Neoplasma. 2019;66(5):825-9.Search in Google Scholar

21Wang T, Liu X, Tian Q, Liang T, Chang P. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Eur Rev Med Pharmacol Sci. 2017;21(16):3592-7.Search in Google Scholar

22WHO classification of tumours series. In: Head and Neck Tumours, 5th ed. International Agency for Research on Cancer: Lyon, France. 2022;9.Search in Google Scholar

23Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual, 8th ed. Springer: New York, NY, USA; 2017.Search in Google Scholar

24Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J Clin Med. 2018;7(9):241.Search in Google Scholar

25Roden RBS, Stern PL. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat Rev Cancer. 2018;18(4):240-54.Search in Google Scholar

26Vedham V, Divi RL, Starks VL, Verma M. Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat. 2014;13(2):177-94.Search in Google Scholar

27Guidry JT, Scott RS. The interaction between human papillomavirus and other viruses. Virus Res. 2017;231:139-47.Search in Google Scholar

28Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci. 2021;13(1):1-11.Search in Google Scholar

29Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18(1):63.Search in Google Scholar

30Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-37.Search in Google Scholar

31Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013;3(3):227-32.Search in Google Scholar

32Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep. 2012;27(5):1660-8.Search in Google Scholar

33Lamperska KM, Kozlowski P, Kolenda T, Teresiak A, Blizniak R, Przybyla W, et al. Unpredictable changes of selected miRNA in expression profile of HNSCC. Cancer Biomarkers. 2016;16(1):55-64.Search in Google Scholar

34Yan ZY, Luo ZQ, Zhang LJ, Li J, Liu JQ. Integrated analysis and MicroRNA expression profiling identified seven miRNAs associated with progression of oral squamous cell carcinoma. J Cell Physiol. 2017;232(8):2178-85.Search in Google Scholar

35Zheng W, Liu Z, Zhang W, Hu X. miR-31 functions as an oncogene in cervical cancer. Arch Gynecol Obstet. 2015;292(5):1083-9.Search in Google Scholar

36Chen M, Xu Z, Zhang Y, Zhang X. LINC00958 promotes the malignancy of nasopharyngeal carcinoma by sponging microRNA-625 and thus upregulating NUAK1. Onco Targets Ther. 2019;12:9277-90.Search in Google Scholar

37Nakamura K, Hiyake N, Hamada T, Yokoyama S, Mori K, Yamashiro K, et al. Circulating microRNA Panel as a Potential novel biomarker for oral squamous cell carcinoma diagnosis. Cancers (Basel). 2021;13(3):449.Search in Google Scholar

38Wei Z, Lyu B, Hou D, Liu X. Mir-5100 mediates proliferation, migration and invasion of oral squamous cell carcinoma cells via targeting SCAI. J Invest Surg. 2021;34(8):834-41.Search in Google Scholar

39Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6(10):4047-79.Search in Google Scholar

40Vojtechova Z, Tachezy R. The role of miRNAs in virus-mediated oncogenesis. Int J Mol Sci. 2018;19(4):1217.Search in Google Scholar

41Kim S, Park S, Oh JH, Lee SS, Lee Y, Choi J. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression. BMC Oral Health. 2022;22(1):378.Search in Google Scholar

42Fang C, Li Y. Prospective applications of microRNAs in oral cancer. Oncol Lett. 2019;18(4):3974-84.Search in Google Scholar

43Rajan C, Roshan VGD, Khan I, Manasa VG, Himal I, Kattoor J, et al. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma. Sci Rep. 2021;11(1):7298.Search in Google Scholar

44Ogawa H, Nakashiro K, Tokuzen N, Kuribayashi N, Goda H, Uchida D. MicroRNA‐361‐3p is a potent therapeutic target for oral squamous cell carcinoma. Cancer Sci. 2020;111(5):1645-51.Search in Google Scholar

45Gu Y, Tang S, Wang Z, Cai L, Shen Y, Zhou Y. Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma. J Dent Sci. 2022;17(2):666-76.Search in Google Scholar

46Wang J, Lv N, Lu X, Yuan R, Chen Z, Yu J. Diagnostic and therapeutic role of microRNAs in oral cancer. Oncol Rep. 2021;45(1):58-64.Search in Google Scholar